Anthrasil (Cangene Corporation)
Welcome to the PulseAid listing for the Anthrasil drug offered from Cangene Corporation. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Cangene Corporation |
| NON-PROPRIETARY NAME: | Anthrax immune globulin (human) |
| SUBSTANCE NAME: | ANTHRAX IMMUNE GLOBULIN HUMAN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-10-05 |
| END MARKETING DATE: | 0000-00-00 |
Anthrasil PLASMA DERIVATIVE Details:
| Item Description | Anthrasil from Cangene Corporation |
| LABELER NAME: | Cangene Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 60([iU]/35mL) |
| START MARKETING DATE: | 2015-10-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60492-0249_97cc9a89-6fe0-424e-82d1-0cf9d19444db |
| PRODUCT NDC: | 60492-0249 |
| APPLICATION NUMBER: | BLA125562 |
Other ANTHRAX IMMUNE GLOBULIN HUMAN Pharmaceutical Manufacturers / Labelers:
